Literature DB >> 17288886

Headache in pregnancy.

Dawn A Marcus1.   

Abstract

Conventional wisdom teaches that chronic headaches typically improve and often abate during pregnancy, leading many clinicians to take a wait-and-see approach of delaying treatment in hopes of seeing spontaneous improvement. Although headaches do improve in later pregnancy for up to 50% of chronic headache sufferers, headaches persist and may even worsen for the remainder. Clinicians must recognize that treating headache during pregnancy is important in order to limit excessive use of over-the-counter pain remedies, dehydration, and pain- related disability. Safe and effective medication and nonmedication treatment options are available for the pregnant headache sufferer, including both acute care and preventive therapies. Care of the pregnant headache patient should begin before she is known to be pregnant, when the fertile female is initially established as a patient. Preconception planning should include modification of medication regimes to include medications safe for use during early pregnancy, when the woman may not yet realize she is pregnant, and effective nonmedication therapies, such as relaxation, biofeedback, and lifestyle modification.

Entities:  

Year:  2007        PMID: 17288886     DOI: 10.1007/s11940-007-0027-0

Source DB:  PubMed          Journal:  Curr Treat Options Neurol        ISSN: 1092-8480            Impact factor:   3.598


  50 in total

1.  Fluoxetine for migraine prophylaxis: a double-blind trial.

Authors:  C C d'Amato; V Pizza; T Marmolo; E Giordano; V Alfano; A Nasta
Journal:  Headache       Date:  1999 Nov-Dec       Impact factor: 5.887

2.  Impact of Ramadan on demographics and frequencies of disease-related visits in the emergency department.

Authors:  H Topacoglu; O Karcioglu; A Yuruktumen; S Kiran; A H Cimrin; D N Ozucelik; S Sarikaya; S Soysal; U Turpcu; S Bozkurt
Journal:  Int J Clin Pract       Date:  2005-08       Impact factor: 2.503

3.  [Drug use during pregnancy: survey in 250 women consulting at a university hospital center].

Authors:  C Damase-Michel; M Lapeyre-Mestre; C Moly; A Fournié; J L Montastruc
Journal:  J Gynecol Obstet Biol Reprod (Paris)       Date:  2000-02

4.  Women's issues of migraine in tertiary care.

Authors:  Leslie Kelman
Journal:  Headache       Date:  2004-01       Impact factor: 5.887

5.  Maintenance of effects in the nonmedical treatment of headaches during pregnancy.

Authors:  L Scharff; D A Marcus; D C Turk
Journal:  Headache       Date:  1996-05       Impact factor: 5.887

6.  Effects of prenatal exposure to tricyclic antidepressants on adrenergic responses in progeny.

Authors:  J W Simpkins; F P Field; G Torosian; E E Soltis
Journal:  Dev Pharmacol Ther       Date:  1985

7.  Migraine without aura and reproductive life events: a clinical epidemiological study in 1300 women.

Authors:  F Granella; G Sances; C Zanferrari; A Costa; E Martignoni; G C Manzoni
Journal:  Headache       Date:  1993 Jul-Aug       Impact factor: 5.887

Review 8.  Headache in pregnancy.

Authors:  Dawn A Marcus
Journal:  Curr Pain Headache Rep       Date:  2003-08

9.  Intramuscular prochlorperazine versus metoclopramide as single-agent therapy for the treatment of acute migraine headache.

Authors:  J Jones; S Pack; E Chun
Journal:  Am J Emerg Med       Date:  1996-05       Impact factor: 2.469

10.  Randomized, placebo-controlled evaluation of prochlorperazine versus metoclopramide for emergency department treatment of migraine headache.

Authors:  M Coppola; D M Yealy; R A Leibold
Journal:  Ann Emerg Med       Date:  1995-11       Impact factor: 5.721

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.